Research in Sweden led by the University of Uppsala has looked into using mesenchymal stromal cells to halt the progress of newly diagnosed type 1 diabetes. In the paper, "Umbilical cord-derived mesenchymal stromal cells ...
Research led by the Cleveland Clinic in Ohio evaluated postoperative recovery rates from elective surgery in a study, "Association Between Mobilization and Composite Postoperative Complications Following Major Elective Surgery," ...
Bile duct cancers are uncommon and aggressive types of gastrointestinal cancer. They include cholangiocarcinomas, which can form inside or outside of the liver, as well as cancers of the gallbladder, and are highly likely ...
Jun 2, 2023
0
20
According to the federal government's National Institute of Neurological Disorders and Stroke, nearly 3 million people worldwide—with almost a third in the United States—are living with multiple sclerosis (MS), a disabling ...
Jun 2, 2023
0
103
Researchers have for the first time characterized a unique molecular mechanism of the early stages of programmed cell death or apoptosis, a process which plays a crucial role in prevention of cancer.
Jun 2, 2023
0
83
A study involving UCLA Jonsson Comprehensive Cancer Center researchers found when ribociclib, a targeted therapy drug, is added to hormone therapy there are a significant invasive disease-free survival benefit in patients ...
Jun 2, 2023
0
7
In a multi-center phase 1 and 2 trial (BRUIN, NCT03740529), researchers from leading cancer centers across the globe, including the Medical College of Wisconsin (MCW) in Milwaukee, tested Bruton tyrosine kinase inhibitor ...
Jun 2, 2023
0
5
Researchers at the University Health Network and University of Toronto have discovered a new biotherapeutic molecule—produced by a strain of oral probiotic bacteria—that kills infectious pathogens while promoting a healthy ...
Jun 1, 2023
0
29
Chemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of certain cancer treatments, including two drugs frequently used to treat cancer—the ...
Jun 1, 2023
0
2
There's one question that Hollings Cancer Center researcher Jennifer Dahne, Ph.D., co-director of the remote and virtual trials program at the South Carolina Clinical & Translational Research Institute, hears more than any ...
Jun 1, 2023
0
4
